Antitumour activity of arabinogalactan-peptidoglycan (AP) complex (peptidoglycan and arabinogalactan liberated by an acid or alkaline treatment from Rhodococcus lentifragmentus AN-115 cell wall skeleton) was examined in mice and compared with that of the cell wall skeleton. The growth of syngeneic fibrosarcoma Meth A cells after implantation in BALB/c mice was significantly suppressed by AP complex, and also regressed after intratumoral injection of AP complex on days 1,4 and 7 after tumour implantation. Although the activity of peptidoglycan was less than that of AP complex, peptidoglycan also showed both tumoursuppressive and regressive activities. Arabinogalactan did not show antitumour activity. It is interesting that peptidoglycan has an important role in the effect against tumours.
INTRODUCTION
The cell wall skeleton of Rhodococcus lentifragmentus (R-CWS) possesses immunoadjuvant activity for circulating antibody formation (Ohara et al., 1986) , and results in induction of cellmediated immunity and antiturnour activity in experimental animals (Azuma et al., 1976; Yamawaki et al., 1978) . Cell wall skeletons of various bacteria, such as Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8, also have adjuvant activity (Azuma et al., 1975) . These bacteria have similar cell wall constituents: mycolic acid, arabinogalactan and peptidoglycan (Lederer, 1971 ; Michel & Bordet, 1976; Barksdale & Kim, 1977) . Among these constituents, peptidoglycan is responsible for adjuvant activities of cell walls, causing increased serum antibody levels and inducing delayed-type hypersensitivity to ovalbumin (Azuma et al., 1975) . Detailed studies on adjuvant-active units using enzymedegraded components of cell walls (Azuma et al., 1974; Adam et al., 1976) and synthesized model compounds (Adam et al., 1974) have shown that the N-acetylmuramyl-L-alanyl-Disoglutamine (MDP) fragment of peptidoglycan is the minimum unit needed to display the adjuvant activities. However, antitumour activity has not been demonstrated for MDP in experimental tumour systems. Furthermore, little is known about the antitumour activity of peptidoglycan moieties purified from bacterial cell walls, nor is it known how other constituents, especially arabinogalactan, relate to the antitumour activity of peptidoglycan. This paper describes antitumour activity of R-CWS and its constituents including the arabinogalactanpeptidoglycan complex (AP complex), peptidoglycan and arabinogalactan isolated from Rcws.
RESULTS
Chemical composition of R-C WS and constituentspur$ed from it. R-CWS was mainly composed of mycolic acid, arabinogalactan and peptidoglycan. The latter two constituents were bound together by phosphodiester linkages and glycosidic linkages to form the rigid structure of the AP complex (Fujioka et al., 1985) . Mycolic acid was bound to the arabinogalactan moiety of this complex through ester bonds. As shown in Table 1 , the arabinogalactan consisted of arabinose and galactose together with small amounts of rhamnose. The peptidoglycan consisted of glucosamine, muramic acid, alanine, glutamic acid and diaminopimelic acid.
Antiturnour activities of R-C WS and constituents pur$ed from it. AP complex and R-CWS at doses of 10 and 100 pg suppressed the growth of fibrosarcoma Meth A in BALB/c mice ( Table  2) . Peptidoglycan also showed tumour-suppressive activity at a dose of 100 pg, but not at a dose of 1Opg. Arabinogalactan did not suppress tumour growth even at a dose of 1OOpg.
Regression of the growth of Meth A was evident in BALB/c mice that received doses of 100 and 320 pg of AP complex (Table 3) . Peptidoglycan also showed significant tumour-regressive activity at a dose of 320 pg (Table 4) . No tumour-regressive activity was observed in the case of arabinogalactan; its effect was similar to that seen in the suppression test (data not shown).
DISCUSSION
Intratumoral administration of the cell wall skeletons of Mycobacterium bouis BCG and of Corynebacterium parvum can protect experimental animals from proliferation of tumours (Azuma et al., 1974) . In the present study, R-CWS also showed strong suppressive and regressive effects on syngeneic fibrosarcoma Meth A in BALB/c mice. Furthermore, significant antitumour activity of the AP complex and peptidoglycan against the Meth A growth was observed.
The minimal adjuvant-active subunit of BCG cell walls is MDP (Elouz et al., 1974 ; Kotani et a/., 1975;  Azuma et al., 1983) . Synthetic N-acetylmuramyl-dipeptide that had potent adjuvant activity in immune systems, however, proved to be active in experimental tumour systems only if administered admixed with trehalose dimycolate (McLaughlin et al., 1980;  Yarconi et al., 1981) , or incorporated into liposomes (Fidler et al., 1981) . Saiki et al. (1982) speculated that the Meth A cells (1 x lo5) were implanted intradermally on day 0 and a sample was injected intratumorally on days 1,4 and 7. Ten animals were used in each dose and control group. Tumours were dissected out and weighed on day 14. The numbers in parentheses show the tumour growth inhibition rate : (1 -T/C)
x 100 (%), where T is the tumour weight of the sample-treated group and C is the tumour weight of the placebo-treated control group.
Mean tumour wt (mg) on day 14, f SE Dose t Significantly different from the same dose group of R-CWS (P < 0.05).
Table 4. Eflect of'peptidoglycan on growth of syngeneicjbrosarcoma Meth A in BALBlc mice
Meth A cells (1 x lo5) were implanted intradermally on day 0, and a sample was injected intratumorally on days 1, 4 and 7. Ten animals were used in each dose and control group. The tumour growth inhibition rate (%) is shown in parentheses. For other information, see Table 3 . lack of antitumour activity of MDP might be due to its low molecular weight and water solubility. N-Acetylmuramyl-dipeptide with mycolic acid bound to the 6-0-position of its muramic acid residue showed suppressive activity against experimental murine tumour growth in syngeneic mice (Kusumoto et al., 1978 ). Hrsak et al. (1983 reported that intratumorally administered peptidoglycan monomer, isolated from Brevibacterium divaricaturn cell wall, inhibited the nodule growth of B-16 melanoma at a relatively high dose (1 mg per site). Peptidoglycan from acid-treated R-CWS contained a minute fraction of lipid (see Table 1 ). Since it seems unlikely that the lipid component is responsible for the antitumour activity of the peptidoglycan fraction, peptidoglycan is considered to be essentially the antitumour-active moiety and needs its polymer structure to display strong antitumour activity. Saiki et al. (1982) and Kamisango et al. (1982) reported that peptidoglycan was obtained by mild acid treatment from the cell wall skeleton of Listeria monocytogenes without influencing its chemical nature or decreasing its adjuvant and antitumour activities. In the present experiments, however, the antitumour activity of peptidoglycan purified from R-CWS was less than that of the AP complex and R-CWS. Azuma et al. (1975) have shown that adjuvant activities of cell wall skeletons of M . bovis BCG and N . asteroides after acid treatment (peptidoglycan) significantly decreased because of the drastic acid treatment (0.1 M-HCl, 60 "C, 24 h).
Arabinogalactan itself showed no significant antitumour activity. However, the present results suggest that arabinogalactan enhances the antitumour activity of peptidoglycan, as judged by the difference in activities between peptidoglycan and the AP complex.
